Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Margaretha De Vos

Biographic Data

ID9067727
NAMEMargaretha De Vos
GIVEN NAMESMargaretha
FAMILY NAMEDe Vos
SIGNATUREDE VOS M
AFFILIATIONSFIND
ORCID0000-0003-3059-2986
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
AUTHOR COUNT3
EDITOR COUNT0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2023
H-INDEX0
  • Evaluating diagnostic tests during outbreaks

    Open Access•Camille Escadafal, Rossella Baldan et al.•ARTICLE•BMJ Global Health•2023

  • Impact of a multi-disease integrated screening and diagnostic model for Covid-19, TB, and HIV in Lesotho

    Open Access•Bulemba Katende, Moniek Bresser et al.•ARTICLE•PLOS Global Public Health•2023

    The surge of the COVID-19 pandemic challenged health services globally, and in Lesotho, the HIV and tuberculosis (TB) services were similarly affected. Integrated, multi-disease diagnostic services were proposed solutions to mitigate these disruptions. We describe and evaluate the effect of an integrated, hospital-based COVID-19, TB and HIV screening and diagnostic model in two rural districts in Lesotho, during the period between December 2020 a…

  • Diagnostic performance of four lateral flow immunoassays for Covid-19 antibodies in Peruvian population

    Open Access•Rodrigo Calderon-Flores, Guillermo Caceres-Cardenas et al.•ARTICLE•PLOS Global Public Health•2023

    Serological assays have been used in seroprevalence studies to inform the dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for this objective; however, one of their challenges may be variable diagnostic performance. Given the numerous available LFIA tests, evaluation of their accuracy is critical before real-world implementation. We performed a retrospective diagnostic evaluation study to independ…

No prominent works on this page.

  • Evaluating diagnostic tests during outbreaks

    Open Access•Camille Escadafal, Rossella Baldan et al.•ARTICLE•BMJ Global Health•2023

  • Impact of a multi-disease integrated screening and diagnostic model for Covid-19, TB, and HIV in Lesotho

    Open Access•Bulemba Katende, Moniek Bresser et al.•ARTICLE•PLOS Global Public Health•2023

    The surge of the COVID-19 pandemic challenged health services globally, and in Lesotho, the HIV and tuberculosis (TB) services were similarly affected. Integrated, multi-disease diagnostic services were proposed solutions to mitigate these disruptions. We describe and evaluate the effect of an integrated, hospital-based COVID-19, TB and HIV screening and diagnostic model in two rural districts in Lesotho, during the period between December 2020 a…

  • Diagnostic performance of four lateral flow immunoassays for Covid-19 antibodies in Peruvian population

    Open Access•Rodrigo Calderon-Flores, Guillermo Caceres-Cardenas et al.•ARTICLE•PLOS Global Public Health•2023

    Serological assays have been used in seroprevalence studies to inform the dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for this objective; however, one of their challenges may be variable diagnostic performance. Given the numerous available LFIA tests, evaluation of their accuracy is critical before real-world implementation. We performed a retrospective diagnostic evaluation study to independ…

Disease (3 works) · Medicine (3 works) · COVID-19 Clinical Research Studies (2 works) · Internal Medicine (2 works) · Pandemic (2 works) · Pathology (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · SARS-CoV-2 detection and testing (2 works) · Virology (2 works) · 2019-20 coronavirus outbreak (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae